These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 31574527)
1. PAI-1 Gene Polymorphism Was Associated with an Increased Risk of Allergic Diseases: Evidence from a Meta-Analysis of 14 Case-Control Studies. Zheng L; Li X; Song Q; Hou C; Chen X; Li B Int Arch Allergy Immunol; 2019; 180(4):255-263. PubMed ID: 31574527 [TBL] [Abstract][Full Text] [Related]
2. The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis. Nie W; Li B; Xiu QY PLoS One; 2012; 7(3):e34385. PubMed ID: 22479620 [TBL] [Abstract][Full Text] [Related]
3. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis. Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536 [TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 gene 4G/5G polymorphism in Turkish children with asthma and allergic rhinitis. Ozbek OY; Ataç FB; Ogus E; Ozbek N Allergy Asthma Proc; 2009; 30(1):41-6. PubMed ID: 19063817 [TBL] [Abstract][Full Text] [Related]
5. Association between the PAI-1 4G/5G Gene Polymorphism and the Risk of Systemic Lupus Erythematosus/Lupus Nephritis. Li W; Mao S; Wu L; Shi W; Zhang J; Wang Z Crit Rev Eukaryot Gene Expr; 2019; 29(1):85-94. PubMed ID: 31002598 [TBL] [Abstract][Full Text] [Related]
6. Association between plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and risk of Alzheimer's disease, metabolic syndrome, and female infertility: A meta-analysis. Zhang X; Gao B; Xu B Medicine (Baltimore); 2020 Dec; 99(50):e23660. PubMed ID: 33327353 [TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss. Li X; Liu Y; Zhang R; Tan J; Chen L; Liu Y Med Sci Monit; 2015 Apr; 21():1051-6. PubMed ID: 25862335 [TBL] [Abstract][Full Text] [Related]
8. Association Between Plasminogen Activator Inhibitor-1 Genetic Polymorphisms and Stroke Susceptibility. Hu X; Zan X; Xie Z; Li Y; Lin S; Li H; You C Mol Neurobiol; 2017 Jan; 54(1):328-341. PubMed ID: 26742513 [TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis. Li YY PLoS One; 2012; 7(4):e33511. PubMed ID: 22496752 [TBL] [Abstract][Full Text] [Related]
10. Association between plasminogen activator inhibitor-1 -675 4G/5G polymorphism and sepsis: a meta-analysis. Li L; Nie W; Zhou H; Yuan W; Li W; Huang W PLoS One; 2013; 8(1):e54883. PubMed ID: 23382992 [TBL] [Abstract][Full Text] [Related]
11. PAI-1 4G/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysis. Wang S; Cao Q; Wang X; Li B; Tang M; Yuan W; Fang J; Qian J; Qin C; Zhang W PLoS One; 2013; 8(2):e56797. PubMed ID: 23437240 [TBL] [Abstract][Full Text] [Related]
12. The -675 4G/5G plasminogen activator inhibitor-1 promoter polymorphism in house dust mite-sensitive allergic asthma patients. Pampuch A; Kowal K; Bodzenta-Lukaszyk A; Di Castelnuovo A; Chyczewski L; Donati MB; Iacoviello L Allergy; 2006 Feb; 61(2):234-8. PubMed ID: 16409202 [TBL] [Abstract][Full Text] [Related]
13. Polymorphism 4G/5G of the plasminogen activator inhibitor 1 gene as a risk factor for the development of allergic rhinitis symptoms in patients with asthma. Lampalo M; Jukic I; Bingulac-Popovic J; Marunica I; Petlevski R; Pavlisa G; Popovic-Grle S Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2613-2619. PubMed ID: 28258374 [TBL] [Abstract][Full Text] [Related]
14. Association between PAI-1 4G/5G polymorphism and diabetic nephropathy: a meta-analysis in the Chinese population. Gao WF; Guo YB; Bai Y; Ding XY; Yan YJ; Wu ZQ Int Urol Nephrol; 2016 Sep; 48(9):1483-9. PubMed ID: 27272255 [TBL] [Abstract][Full Text] [Related]
15. Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis. Gong LL; Peng JH; Han FF; Zhu J; Fang LH; Wang YH; Du GH; Wang HY; Liu LH Thromb Res; 2012 Sep; 130(3):e43-51. PubMed ID: 22771216 [TBL] [Abstract][Full Text] [Related]
16. Plasminogen Activator Inhibitor-1 Polymorphism Confers a Genetic Contribution to the Risk of Recurrent Spontaneous Abortion: An Updated Meta-Analysis. Huang Z; Tang W; Liang Z; Chen Q; Li M; Li Y; Lao S; Pan H; Huang L; Huang M; Hu X; Zhao J Reprod Sci; 2017 Nov; 24(11):1551-1560. PubMed ID: 28395596 [TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 -675 4G/5G polymorphism and polycystic ovary syndrome risk: a meta analysis. Liu Y; Sun MG; Jiang R; Ding R; Che Z; Chen YY; Yao CJ; Zhu XX; Cao JY J Assist Reprod Genet; 2014 Mar; 31(3):363-70. PubMed ID: 24435452 [TBL] [Abstract][Full Text] [Related]
18. Association between the 4G/5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene and sudden sensorineural hearing loss in Caucasian population: a meta-analysis. Wei Z; Chang K; Fan C Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2203-2208. PubMed ID: 32901365 [TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis. Zhang T; Pang C; Li N; Zhou E; Zhao K BMC Med; 2013 Jan; 11():1. PubMed ID: 23281898 [TBL] [Abstract][Full Text] [Related]
20. Plasminogen Activator Inhibitor-1 Polymorphisms and Risk of Coronary Artery Disease: Evidence From Meta-Analysis and Trial Sequential Analysis. Tabaei S; Omraninava M; Mehranfar S; Motallebnezhad M; Tabaee SS Biochem Genet; 2022 Oct; 60(5):1409-1445. PubMed ID: 35039979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]